Our Multiple Sclerosis (MS) research group is developing markers of disease activity and progression and trialling innovative therapies to improve the lives of people with MS.
Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system, in which nerve fibres in the brain and spinal cord are damaged, disrupting the flow of information in the brain and between the brain and body.
Over 23,000 people in Australia are affected by MS, which is most often diagnosed in early adulthood and can therefore dramatically impact the social and economic participation of people affected. This gives great urgency to understanding more about the cause, care and possible cure of the disease.
Phone: +61 2 9351 0730
Email: info@sydneyneurology.com.au
Fax: 9351 0653
Lvl 4, 94 Mallett Street, Camperdown NSW 2050
Opening hours: Monday to Friday, 9am to 5pm